Notification to list medical devices supplied by Downs Distributors Limited and Surgico Medical and Surgical Limited

What we’re doing

In summary this will result in:

• Downs’ and Surgico’s Orthopaedic Products and Single Use Instruments being listed in the Pharmaceutical Schedule from 1 June 2018 under national listing agreements that all DHBS may purchase under (the “Agreements”).
• DHBs continuing to be able to purchase other suppliers’ brands of Orthopaedic Products and Single Use Instruments as the Agreements are not for sole supply.
• Savings of approximately $16,000 across all DHBs, based on historical volumes.

These decisions were subject to a consultation letter dated 23 March 2018. No changes have been made to the Agreements as a result of consultation feedback. 

• Suppliers and Wholesalers
• DHB Staff
• Orthopaedic Surgeons
• Theatre and Sterile Services Personnel
• Procurement and supply chain personnel

In 2016 PHARMAC issued separate Requests for Proposals (“RFPs”) for Orthopaedic Products and Single Use Instruments. The RFPs requested proposals for non-exclusive national agreements for listing in the Pharmaceutical Schedule.

After completing the RFP evaluation process, and consulting on the provisional Agreements reached with Downs and Surgico, PHARMAC has decided to list Downs’ and Surgico’s Orthopaedic Products and Single Use Instruments in Part III of Section H of the Pharmaceutical Schedule from 1 June 2018.

The range of medical devices included in the Agreements is set out below:

The list of products will be available on PHARMAC's website from 1 June 2018, in both a PDF document and an Excel spreadsheet.

DHBs that purchase Downs’ and Surgico’s ranges of Orthopaedic Products and Single Use Instruments must do so under the terms and conditions, and at the prices, included in the Agreements, from 1 June 2018.

DHBs can continue to choose which Orthopaedic Products and Single Use Instruments they purchase.

Educational services will be provided by the suppliers, on the appropriate use of their medical devices, at times as agreed with individual DHBs.

These Agreements are the latest to be approved in these categories and further consultations in these categories are expected over the next few months.

We appreciate the time people took to respond to this consultation.

All consultation responses received by 17 April 2018 were considered in their entirety in making a decision to approve the provisional Agreements.

A summary of the feedback and our responses to the feedback received are set out below:

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.